FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2162088254> ?p ?o ?g. }

• W2162088254 endingPage "891" @default.
• W2162088254 startingPage "883" @default.
• W2162088254 abstract "Background. Antiretroviral treatment (ART) programs in sub-Saharan Africa have for many years included lamivudine as the sole hepatitis B virus (HBV) inhibitor. Long-term outcomes and the effects of introducing tenofovir as part of ART in these populations have not been characterized. Methods. The study comprised a cross-sectional analysis of 106 human immunodeficiency virus (HIV)/HBV–coinfected subjects maintained on lamivudine, as well as a prospective analysis of 76 lamivudine-experienced subjects who introduced tenofovir. Patients underwent assessment of liver fibrosis by transient elastography (TE) and testing to characterize HIV type 1 (HIV-1) and HBV replication. Results. After a median of 45 months of lamivudine treatment, HIV-1 RNA and HBV DNA were detectable in 35 of 106 (33.0%) and 54 of 106 (50.9%) subjects, respectively, with corresponding drug resistance rates of 17 of 106 (16.0%) and 31 of 106 (29.2%), respectively. Median TE values were 5.7 kPa (interquartile range, 4.7–7.2 kPa) and independently associated with HBV DNA load, aspartate aminotransferase levels, and platelet counts; 13 of 106 (12.3%) subjects had TE measurements >9.4 kPa. Twelve months after the first assessment, and a median of 7.8 months after introducing tenofovir, HBV DNA levels declined by a mean of 1.5 log10 IU/mL (P < .001). TE values changed by a mean of −0.2 kPa (P = .097), and declined significantly in subjects who had pretenofovir HBV DNA levels >2000 IU/mL (mean, −0.8 kPa; P = .048) or TE values >7.6 kPa (mean, −1.2 kPa; P = .021). HIV-1 RNA detection rates remained unchanged. Conclusions. A proportion of HIV/HBV-coinfected patients on long-term lamivudine-containing ART had poor HIV and HBV suppression, drug resistance, and TE values indicative of advanced liver fibrosis. Tenofovir improved HBV control and reduced liver stiffness in subjects with high HBV DNA load and TE values." @default.
• W2162088254 created "2016-06-24" @default.
• W2162088254 creator A5000759820 @default.
• W2162088254 creator A5006129426 @default.
• W2162088254 creator A5012901945 @default.
• W2162088254 creator A5014921958 @default.
• W2162088254 creator A5044011096 @default.
• W2162088254 creator A5052742729 @default.
• W2162088254 creator A5054324011 @default.
• W2162088254 creator A5067978004 @default.
• W2162088254 creator A5072739448 @default.
• W2162088254 creator A5076703292 @default.
• W2162088254 date "2015-05-28" @default.
• W2162088254 modified "2023-10-07" @default.
• W2162088254 title "Liver Fibrosis by Transient Elastography and Virologic Outcomes After Introduction of Tenofovir in Lamivudine-Experienced Adults With HIV and Hepatitis B Virus Coinfection in Ghana" @default.
• W2162088254 cites W1978091752 @default.
• W2162088254 cites W2001682560 @default.
• W2162088254 cites W2004100607 @default.
• W2162088254 cites W2005106776 @default.
• W2162088254 cites W2014097029 @default.
• W2162088254 cites W2021109749 @default.
• W2162088254 cites W2022532567 @default.
• W2162088254 cites W2046622424 @default.
• W2162088254 cites W2049211538 @default.
• W2162088254 cites W2050757090 @default.
• W2162088254 cites W2053051468 @default.
• W2162088254 cites W2059560167 @default.
• W2162088254 cites W2070341160 @default.
• W2162088254 cites W2076321611 @default.
• W2162088254 cites W2076506726 @default.
• W2162088254 cites W2090738619 @default.
• W2162088254 cites W2091706522 @default.
• W2162088254 cites W2093904708 @default.
• W2162088254 cites W2099184552 @default.
• W2162088254 cites W2103153013 @default.
• W2162088254 cites W2110647763 @default.
• W2162088254 cites W2114757306 @default.
• W2162088254 cites W2116214343 @default.
• W2162088254 cites W2126536198 @default.
• W2162088254 cites W2141332320 @default.
• W2162088254 cites W2143326808 @default.
• W2162088254 cites W2158274492 @default.
• W2162088254 cites W2159607195 @default.
• W2162088254 cites W2163053606 @default.
• W2162088254 cites W2332247812 @default.
• W2162088254 cites W2332787577 @default.
• W2162088254 doi "https://doi.org/10.1093/cid/civ421" @default.
• W2162088254 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26021992" @default.
• W2162088254 hasPublicationYear "2015" @default.
• W2162088254 type Work @default.
• W2162088254 sameAs 2162088254 @default.
• W2162088254 citedByCount "48" @default.
• W2162088254 countsByYear W21620882542015 @default.
• W2162088254 countsByYear W21620882542016 @default.
• W2162088254 countsByYear W21620882542017 @default.
• W2162088254 countsByYear W21620882542018 @default.
• W2162088254 countsByYear W21620882542019 @default.
• W2162088254 countsByYear W21620882542020 @default.
• W2162088254 countsByYear W21620882542021 @default.
• W2162088254 countsByYear W21620882542022 @default.
• W2162088254 countsByYear W21620882542023 @default.
• W2162088254 crossrefType "journal-article" @default.
• W2162088254 hasAuthorship W2162088254A5000759820 @default.
• W2162088254 hasAuthorship W2162088254A5006129426 @default.
• W2162088254 hasAuthorship W2162088254A5012901945 @default.
• W2162088254 hasAuthorship W2162088254A5014921958 @default.
• W2162088254 hasAuthorship W2162088254A5044011096 @default.
• W2162088254 hasAuthorship W2162088254A5052742729 @default.
• W2162088254 hasAuthorship W2162088254A5054324011 @default.
• W2162088254 hasAuthorship W2162088254A5067978004 @default.
• W2162088254 hasAuthorship W2162088254A5072739448 @default.
• W2162088254 hasAuthorship W2162088254A5076703292 @default.
• W2162088254 hasBestOaLocation W21620882541 @default.
• W2162088254 hasConcept C119060515 @default.
• W2162088254 hasConcept C126322002 @default.
• W2162088254 hasConcept C142462285 @default.
• W2162088254 hasConcept C159047783 @default.
• W2162088254 hasConcept C2522874641 @default.
• W2162088254 hasConcept C2777382497 @default.
• W2162088254 hasConcept C2777813720 @default.
• W2162088254 hasConcept C2777869810 @default.
• W2162088254 hasConcept C2780559512 @default.
• W2162088254 hasConcept C2780593183 @default.
• W2162088254 hasConcept C2780826214 @default.
• W2162088254 hasConcept C2994217296 @default.
• W2162088254 hasConcept C71924100 @default.
• W2162088254 hasConcept C90924648 @default.
• W2162088254 hasConceptScore W2162088254C119060515 @default.
• W2162088254 hasConceptScore W2162088254C126322002 @default.
• W2162088254 hasConceptScore W2162088254C142462285 @default.
• W2162088254 hasConceptScore W2162088254C159047783 @default.
• W2162088254 hasConceptScore W2162088254C2522874641 @default.
• W2162088254 hasConceptScore W2162088254C2777382497 @default.
• W2162088254 hasConceptScore W2162088254C2777813720 @default.
• W2162088254 hasConceptScore W2162088254C2777869810 @default.
• W2162088254 hasConceptScore W2162088254C2780559512 @default.
• W2162088254 hasConceptScore W2162088254C2780593183 @default.
• W2162088254 hasConceptScore W2162088254C2780826214 @default.

• next